• Our Way
  • About CANCER FUND I
    • PORTFOLIO
      • Reglagene
      • Metabolytix
    • Capital
  • Invest
  • Our Team
  • Our Community
    • The Lowdown on Cancer Blog
    • Celebrations
      • Celebrate Your Cancer Hero
    • Community Stories
      • Share Your Story
    • Subscribe
  • FAQ
INVEST $500 OR MORE

Save Second Base, The Innovators: Raadysan BioTech

by shoshana | Jul 26, 2021 | Breast Cancer, Innovators

Triple-Negative Breast Cancer makes up about 10-20% of breast cancer diagnoses and is more aggressive than other breast cancer types. Which means it has a worse prognosis. It’s also more common among younger women, black and Hispanic women, and those with the BRCA1...

Save Second Base, The Innovators: Concarlo Holdings, LLC

by shoshana | Jul 15, 2021 | Breast Cancer, Innovators

We’ve shared some gut-wrenching stories as part of “Save Second Base,” our series on breast cancer. But now we share some glimmers of hope. CANCER FUND is more than hope. Through investing in innovation, we bring diagnostics, treatments, and...

Bonnie & Kent: Husband and Wife Joined In Breast Cancer

by shoshana | Jul 7, 2021 | Breast Cancer, CANCER FUND, Personal Journeys, The Bitch is Back

Kent was traveling a lot for work, enjoying life with his wife, Bonnie, on the weekends. “Life was running smooth.” Then Kent discovered a lump in his breast, by his nipple. “Like any red-blooded American male, I ignored it!” It wasn’t until he noticed his inverted...

Recent Posts

  • The Game of Medical Breakthroughs (and Their Funding)
  • Thanksgiving 2021
  • Saving Second Base: Recapping Our Second Innovators
  • Save Second Base, The Innovators: Onco-liq
  • Save Second Base, The Innovators: Telexos GmbH

Recent Comments

  • Elsa González on Save Second Base, The Innovators: Onco-liq
  • Mary Reed on Save Second Base, The Innovators: Onco-liq
  • Margarita on Save Second Base, The Innovators: Onco-liq
  • SYLVIA THOMAS on Save Second Base, The Innovators: Onco-liq
  • Marian Bergter on Save Second Base, The Innovators: Onco-liq

Archives

  • February 2022
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • May 2020

Categories

  • Access to Care
  • Breast Cancer
  • CANCER FUND
  • Care
  • Contributors
  • Innovators
  • My Lowdown
  • Personal Journeys
  • Race For A Cure Stalled?
  • The Bitch is Back
  • The Lowdown on Lowdown
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Follow
  • Follow

Terms Of ServicePrivacy PolicyContact Us

© 2022 CANCER FUND. All rights reserved

*DISCLAIMER: Our visitors acknowledge that: (1) CANCER FUND is not now by this website and the information shown herein offering any securities, nor soliciting an offer to buy any securities; (2) this website and the information herein shall not be construed as any description of the business of CANCER FUND in conjunction with any offering of securities; (3) the information contained on this website is subject to change without notice, and no one shall assume from the availability of this website and the information herein that the affairs of CANCER FUND have not changed since the date of this information; (4) CANCER FUND is neither soliciting nor collecting donations and that any charitable contributions are made through BioAccel, a tax-exempt entity under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302 whose mission of is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support; information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission; and (5) donations solicited and accepted by BioAccel are limited to Arizona, Idaho, Indiana, Montana, Nebraska, South Dakota, Vermont, Wyoming and Puerto Rico.

 

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.

*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.